Viewing Study NCT00616161


Ignite Creation Date: 2025-12-24 @ 12:03 PM
Ignite Modification Date: 2025-12-27 @ 4:06 PM
Study NCT ID: NCT00616161
Status: COMPLETED
Last Update Posted: 2008-02-15
First Post: 2008-02-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Trial to Assess Hemodynamic Effects of Istaroxime in Pts With Worsening HF and Reduced LV Systolic Function
Sponsor: sigma-tau i.f.r. S.p.A.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-08
Start Date Type: None
Primary Completion Date: 2007-07
Primary Completion Date Type: ACTUAL
Completion Date: 2007-08
Completion Date Type: ACTUAL
First Submit Date: 2008-02-05
First Submit QC Date: None
Study First Post Date: 2008-02-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2008-02-05
Last Update Post Date: 2008-02-15
Last Update Post Date Type: ESTIMATED